This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 could change in day-to-day care and decision-making.
In Tempe
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.